Evidence map›Paper›PMID 36074223›Full record

ArticleMolecular imaging and biology2023

Cerebrovascular G

Salvador Castaneda-Vega, Sandra Beer-Hammer, Veronika Leiss, Hanna Napieczyńska, Marta Vuozzo, Andreas M Schmid, Hang Zeng, Yi He, Ursula Kohlhofer, Irene Gonzalez-Menendez and 6 more

Open access · hybridFull text read
In one paragraph

Article in Molecular imaging and biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Evaluating Postoperative Hidden Blood Loss in Proximal Femoral Nail Anti-Rotation Fixation: The Role of Greater Trochanter Fracture Comminution.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Salvador Castaneda-VegaWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.ORCID 0000-0002-0484-9904
Sandra Beer-HammerDepartment of Pharmacology, Experimental Therapy and Toxicology, and Interfaculty Center for Pharmacogenomics and Drug Research, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.
Veronika LeissDepartment of Pharmacology, Experimental Therapy and Toxicology, and Interfaculty Center for Pharmacogenomics and Drug Research, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.
Hanna NapieczyńskaWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.
Marta VuozzoWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.
Andreas M SchmidWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.
Hang ZengHigh Field Magnetic Resonance Department, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
Yi HeHigh Field Magnetic Resonance Department, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
Ursula KohlhoferInstitute of Pathology and Neuropathology, Eberhard Karls University and Comprehensive Cancer Center, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.
Irene Gonzalez-MenendezCluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.
Leticia Quintanilla-MartinezCluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.
Johann-Martin HempelDepartment of Diagnostic and Interventional Neuroradiology, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany.
Maik GollaschExperimental and Clinical Research Center (ECRC), A Joint Cooperation Between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Xin YuHigh Field Magnetic Resonance Department, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
Bernd J PichlerWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany. Bernd.pichler@med.uni-tuebingen.de.
Bernd NürnbergDepartment of Pharmacology, Experimental Therapy and Toxicology, and Interfaculty Center for Pharmacogenomics and Drug Research, Eberhard Karls University Tübingen and University Clinic, Tübingen, Germany. Bernd.nuernberg@uni-tuebingen.de.ORCID 0000-0002-5995-6555
University of Tübingen · DESiemens (Germany) · DEMax Planck Institute for Biological Cybernetics · DEHarvard University · USMax Delbrück Center · DE

Funding

Investigating the Thalamic Regulation of Neuro-Glio-Vascular Restoration Underlying Acute Coma Recovery with Multi-Modal fMRI in a Brainstem Coma Rodent ModelR01NS122904 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XIN · 2021 to 2025
$3.2M
Investigating the neurophysiological basis of circuit-specific laminar rs-fMRIRF1NS124778 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BISWAL, BHARAT BHUSAN, BROWN, EMERY N · 2022 to 2022
$2.1M
Develop a multi-modal cross-scale fMRI platform with laminar-specific cellular recordings through multi-channel tapered photonic crystal fiber arrayRF1NS113278 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XIN · 2019 to 2019
$2.0M
Bridging the cellular and microvascular anatomy and functional dynamics: Upgrade the 14T horizontal MR for rodent and ex-vivo imagingS10MH124733 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R, YU, XIN · 2020 to 2020
$600k
Upgrade the 14T Ultrahigh Field Horizontal MR Scanner for Rodent and ex-vivo ImagingS10OD028616 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 2021 to 2021
$600k
Development of a Multi-Modal MRI Methodology to Map Paravascular Clearance Linked to Astrocyte Dysfunction in Fetal-Onset HydrocephalusR21NS121642 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XIN · 2021 to 2021
$462k
NIH HHS S10 OD028616NIMH NIH HHS S10 MH124733NINDS NIH HHS R01 NS122904NINDS NIH HHS R21 NS121642NINDS NIH HHS RF1 NS113278NINDS NIH HHS RF1 NS124778
6 · The paper itself

Abstract

Cerebral hypoperfusion and vascular dysfunction are closely related to common risk factors for ischemic stroke such as hypertension, dyslipidemia, diabetes, and smoking. The role of inhibitory G protein-dependent receptor (G

Indexed as

Brain IschemiaStrokeAnimalsBrainCerebral InfarctionGTP-Binding ProteinsGTP-Binding ProteinsCerebral microvesselsG proteinIschemic strokeMRIPertussis toxin

Identifiers

PMID36074223
PMCPMC10006265
OpenAlexW4294991405

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read17
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.